Filing Flows › Journey Medical (DERM) › R&D spending
Journey Medical (DERM) R&D spending by quarter
Journey Medical's R&D spending was $54K in Q2 2026 (second quarter 2026), -65% from Q4 2025. Over the last 4 quarters it ranged from $39K (Q1 2025) to $287K (Q3 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $54K | -65% | — |
| Q4 2025 | $154K | -46% | — |
| Q3 2025 | $287K | +636% | — |
| Q1 2025 | $39K | — | — |
Q2 2026 at a glance
Journey Medical, Q2 2026: revenue $18.5M (+23% year over year), operating margin 2.5%, net loss $312K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Journey Medical's R&D spending?
Journey Medical's R&D spending was $54K in Q2 2026 (second quarter 2026), -65% from Q4 2025.
How has Journey Medical's R&D spending changed?
Over the last 4 quarters it ranged from $39K (Q1 2025) to $287K (Q3 2025).